vimarsana.com

Page 89 - ஒன்றுபட்டது கிஂக்டம் பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

欧盟将不再与阿斯利康及强生疫苗续约,专家建议日本再次宣布紧急状态 | 国际疫情观察(4月15日)

欧盟将不再与阿斯利康及强生疫苗续约,专家建议日本再次宣布紧急状态 | 国际疫情观察(4月15日)
sina.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.cn Daily Mail and Mail on Sunday newspapers.

Denmark ditches AstraZeneca s COVID-19 shot over blood clot risk | Coronavirus pandemic News

Denmark has become the first country to halt all use of AstraZeneca’s COVID-19 vaccine after recent reports of rare but serious side effects among a small minority of recipients of the shot. The move will push back the scheduled conclusion of the Scandinavian country’s vaccination scheme to early August from July 25. It comes despite recommendations from the World Health Organization and the European Medicines Agency (EMA) – the European Union’s medicines regulator – to continue using the AstraZeneca vaccine. Both bodies have repeatedly said the benefits of the shot outweigh any potential risks associated with its use after its use was linked to several cases of severe blood clots, some of which proved fatal.

Denmark ditches AstraZeneca s COVID-19 shot over blood clot risk

Denmark ditches AstraZeneca’s COVID-19 shot over blood clot risk Al Jazeera English © The European Union s medicines regulator and the World Health Organization have said the benefits of. Denmark s move comes despite recommendations from the World Health Organization and the European Medicines Agency (EMA) - the European Union s medicines regulator - to continue using the AstraZeneca vaccine [File: Hannibal Hanschke/Reuters] Denmark has become the first country to halt all use of AstraZeneca’s COVID-19 vaccine after recent reports of rare but serious side effects among a small minority of recipients of the shot. The move will push back the scheduled conclusion of the Scandinavian country’s vaccination scheme to early August from July 25.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.